Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10635)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 27, 2022 (publication date) through Dec 7, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Aljabban J, Rohr M, Syed S, Khorfan K, Borkowski V, Aljabban H, Segal M, Mukhtar M, Mohammed M, Panahiazar M, Hadley D, Spengler R, Spengler E. Transcriptome changes in stages of non-alcoholic fatty liver disease. World J Hepatol 2022; 14(7): 1382-1397 [PMID: 36158924 DOI: 10.4254/wjh.v14.i7.1382] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Aljabban J, Rohr M, Syed S, Khorfan K, Borkowski V, Aljabban H, Segal M, Mukhtar M, Mohammed M, Panahiazar M, Hadley D, Spengler R, Spengler E. Transcriptome changes in stages of non-alcoholic fatty liver disease. World J Hepatol 2022; 14(7): 1382-1397 [PMID: 36158924 DOI: 10.4254/wjh.v14.i7.1382] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i7/1382.htm |
| Number | Citing Articles |
| 1 |
Elena Cristina Rusu, Helena Clavero-Mestres, Mario Sánchez-Álvarez, Marina Veciana-Molins, Laia Bertran, Pablo Monfort-Lanzas, Carmen Aguilar, Javier Camaron, Teresa Auguet. Uncovering hepatic transcriptomic and circulating proteomic signatures in MASH: A meta-analysis and machine learning-based biomarker discovery. Computers in Biology and Medicine 2025; 191: 110170 doi: 10.1016/j.compbiomed.2025.110170
|
| 2 |
Bingbing Wang, Siyi Wu, Zuxiong Huang, Wenhui Zhang, Han Sun, Lingling Zhu, Yanxin Huang, Aili Zhao, Wenxiang Wang. Enteromorpha Polysaccharides Alleviate High‐Fat Diet‐Induced Glucolipid Metabolism Disorders via the K18‐Mediated IRS‐1/PI3K/AKT/GSK3β Pathway. Journal of Food Science 2025; 90(11) doi: 10.1111/1750-3841.70713
|
| 3 |
Mohammadreza Gholamrezapour, Raziyeh Taghizadeh Ghavamabadi, Mohammad Mohsen Taghavi, Samereh Dehghani Soltani, Ahmad Shabanizadeh, Reza Vazirinejad, Zahra Taghipour. Efect of N-acetylcysteine on HepG2 cells which were induced into fatty liver cells. Journal of Molecular Histology 2025; 56(1) doi: 10.1007/s10735-024-10313-2
|
| 4 |
Natacha Cerisier, Bryan Dafniet, Anne Badel, Olivier Taboureau. Linking chemicals, genes and morphological perturbations to diseases. Toxicology and Applied Pharmacology 2023; 461: 116407 doi: 10.1016/j.taap.2023.116407
|
| 5 |
Ruiyi Liu, Yan Sun, Dong Di, Xiyuan Zhang, Boran Zhu, Haoxin Wu.
PI3K/AKT/SERBP-1 pathway regulates
Alisma orientalis
beverage treatment of atherosclerosis in APOE
−/−
high-fat diet mice
. Pharmaceutical Biology 2023; 61(1): 473 doi: 10.1080/13880209.2023.2168020
|
| 6 |
Miguel D. Ferrer, Clara Reynés, Margalida Monserrat-Mesquida, Magdalena Quetglas-Llabrés, Cristina Bouzas, Silvia García, David Mateos, Miguel Casares, Cristina Gómez, Lucía Ugarriza, Josep A. Tur, Antoni Sureda, Antoni Pons. Polyunsaturated and Saturated Oxylipin Plasma Levels Allow Monitoring the Non-Alcoholic Fatty Liver Disease Progression to Severe Stages. Antioxidants 2023; 12(3): 711 doi: 10.3390/antiox12030711
|
| 7 |
Bhavani Gadiraju, Jhansi Magisetty, Vijay Kondreddy. Transcription factor ETV4 plays a critical role in the development of non-alcoholic fatty liver disease. International Journal of Biological Macromolecules 2024; 282: 137235 doi: 10.1016/j.ijbiomac.2024.137235
|
| 8 |
Logan Dameris, Joshua Hartsell, Jessie Chappel, Xiaojing Liu, Michael Cowley. Cadmium exposure during adolescence and young adulthood induces signatures of metabolic dysfunction-associated steatotic liver disease. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-22462-9
|
| 9 |
Aylin Acun, Letao Fan, Ruben Oganesyan, Korkut M. Uygun, Heidi Yeh, Martin L. Yarmush, Basak E. Uygun. Effect of Donor Age and Liver Steatosis on Potential of Decellularized Liver Matrices to be used as a Platform for iPSC‐Hepatocyte Culture. Advanced Healthcare Materials 2024; 13(13) doi: 10.1002/adhm.202302943
|
| 10 |
Divyavani Gowda, Chandra Shekhar, Siddabasave Gowda B. Gowda, Yifan Chen, Shu-Ping Hui. Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease. Livers 2023; 3(4): 687 doi: 10.3390/livers3040045
|
| 11 |
Olga Y. Burenina, Roman K. Makarchenko, Maria P. Rubtsova, Olga A. Dontsova. Liver‐specific lncRNAs associated with liver cancers. FEBS Open Bio 2025; 15(9): 1383 doi: 10.1002/2211-5463.70079
|